Related Experiment Video
Updated: Oct 14, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Fatal Scedosporium prolificans infection in a paediatric patient with acute lymphoblastic leukaemia
Abstract:
Scedosporium prolificans is a saprophytic fungus responsible for an increasing number of infections among immunocompromised hosts. Most disseminated S. prolificans infections prove fatal due to persistent neutropenia, and inherited resistance to currently available antifungal drugs. The authors report a fatal case of a paediatric Korean patient who progressed to severe sepsis from S. prolificans infection after induction chemotherapy for acute lymphoblastic leukaemia. Treatment with itraconazole was unsuccessful and the patient died within 6 days of admission.
Insights
Scedosporium prolificans infections are fatal in immunocompromised patients due to drug resistance. This case highlights a fatal Scedosporium prolificans infection in a child with leukemia despite treatment.
Area of Science:
- Mycology
- Infectious Diseases
- Hematology
Background:
- Scedosporium prolificans is a fungus causing infections in immunocompromised individuals.
- Disseminated infections are often fatal due to neutropenia and antifungal drug resistance.
Observation:
- A pediatric Korean patient with acute lymphoblastic leukemia underwent induction chemotherapy.
- The patient developed severe sepsis from Scedosporium prolificans infection.
Findings:
- Treatment with itraconazole was ineffective.
- The patient succumbed to the infection within 6 days of hospital admission.
Implications:
- This case underscores the challenges in treating Scedosporium prolificans infections.
- It highlights the need for novel therapeutic strategies against resistant fungal pathogens in immunocompromised hosts.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025